Back to UBS Group AG UBS Group AG

CLGNCLGN
Showing 6 of 19 quarters

Position history for UBS Group AGUBS Group AG's holdings in COLLPLANT BIOTECHNOLOGIES LT

UBS Group AG holds 1,035 shares of CLGN (COLLPLANT BIOTECHNOLOGIES LT), worth $361 as of 2026-Q2. The position was increased (+989.5% shares).

Current Value

$361

Current Shares

1,035

Total Value Change

-$58,956

Total Shares Change

-10,912

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1,035
+989.5%
$3610.0%$0.35
12
2026-Q1
New
95
-
$510.0%$0.57
17
2025-Q2
Exited
0
-100.0%
$00.0%$1.38
0
2025-Q1
Increased
24,074
+8.4%
$62,1110.0%$2.55
15
2024-Q4
Increased
22,208
+85.9%
$79,9490.0%$3.63
23
2024-Q3
Increased
11,947
+67.3%
$59,3170.0%$4.93
21

Other major holders of CLGN: ARK Investment Management LLC, BROWN ADVISORY INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used